Hillary Clinton fires back at Republican convention speaker

Hillary Clinton hit back at Republican National Convention speaker Natalie Harp after the former Democratic presidential nominee was compared to a villain from the film “It’s a Wonderful Life.”

“In the classic Jimmy Stewart Film ‘It’s a Wonderful Life,’ George Bailey is given a great gift, the chance to see what the world would be like without him. Tonight, Mr. President, we’d like to give you that same gift,” Harp said Monday during the first night of the convention.

“Without you, we’d all be living in Pottersville, sold out to a crooked Mr. — or I should say a crooked Mrs. — Potter with no hope of escape except death itself,” Harp said. 

In Frank Capra’s 1946 Christmas classic, Bailey, played by Stewart, sees the town of Bedford Falls transform into the dark Pottersville in a vision in which he was never born.

Clinton on Tuesday responded to Harp’s criticism by slamming the Trump administration’s handling of the coronavirus pandemic.

“Perhaps a country in which over 170,000 people have died from a containable disease, 30 million are out of work, and American passports don’t gain admittance to most of the world? Oh, wait,” she wrote.

Perhaps a country in which over 170,000 people have died from a containable disease, 30 million are out of work, and American passports don’t gain admittance to most of the world? Oh, wait. https://t.co/FmWaxdm0QM

— Hillary Clinton (@HillaryClinton) August 25, 2020

Harp, an advisory board member for President Trump’s campaign and “right to try” advocate, replied on Tuesday, “I’m alive today because of President @realDonaldTrump. I’m sorry if that disappoints you, @HillaryClinton.”

I’m alive today because of President @realDonaldTrump. I’m sorry if that disappoints you, @HillaryClinton. https://t.co/9aZxjqgtGL

— Natalie Harp – Text TRUMP to 88022 (@NatalieJHarp) August 25, 2020

Harp, who has battled bone cancer, has lauded the president for signing “right to try” legislation into law in 2018, allowing certain terminally ill patients to access some treatments that have not been fully approved by the Food and Drug Administration.